Bioabsorbable nano-micelle hybridized hydrogel scaffold prevents postoperative melanoma recurrence

• DOI: 10.1016/j.jconrel.2023.03.005
• Publication Date: 2023-03-08T17:10:15Z
• Authors: Mingda Zhao; Ruiling Xu; Yuedi Yang; Lei Tong; Jie Liang; Qing Jiang; Yujiang Fan; Xingdong Zhang; Yong Sun
• Keywords: Mice; Doxorubicin; Cell Line, Tumor; Absorbable Implants; Animals; Gelatin; Hydrogels; Melanoma; Micelles

The residual and scattered small tumor tissue or cells after surgery are the main reason for tumor recurrence. Chemotherapy has a powerful ability to eradicate tumors but always accompanied by serious side effects. In this work, tissue-affinity mercapto gelatin (GelS) and dopamine-modified hyaluronic acid (HAD) were employed to fabricate a hybridized cross-linked hydrogel scaffold (HG) by multiple chemical reactions, which could integrate the doxorubicin (DOX) loaded reduction-responsive nano-micelle (PP/DOX) into this scaffold via click reaction to obtain the bioabsorbable nano-micelle hybridized hydrogel scaffold (HGMP). With the degradation of HGMP, PP/DOX was slowly released and formed targeted PP/DOX with degraded gelatin fragments as target molecules, which increased the intracellular accumulation, and inhibited the aggregation of B16F10 cells in vitro. In mouse models, HGMP absorbed the scattered B16F10 cells and released targeted PP/DOX to suppress tumorigenesis. For another, implantation of HGMP at the surgical site reduced the recurrence rate of postoperative melanoma and inhibited the growth of recurrent tumors. Meanwhile, HGMP significantly relieved the damage of free DOX to hair follicle tissue. This bioabsorbable nano-micelle hybridized hydrogel scaffold provided a valuable strategy for adjuvant therapy after tumor surgery.